Severe cachexia in mice inoculated with interferon-gamma-producing tumor cells.

Area of Science:

• Immunology
• Oncology
• Molecular Biology

Background:

• Cancer cachexia is a complex metabolic syndrome characterized by involuntary weight loss and anorexia.
• The precise molecular mechanisms driving cancer cachexia remain incompletely understood.
• Tumor-derived factors are implicated in cachexia pathogenesis, but specific mediators are debated.

Purpose of the Study:

• To investigate the role of Interferon-gamma (IFN-gamma) in the development of cancer cachexia.
• To determine if IFN-gamma produced by tumor cells is sufficient to induce cachexia.
• To elucidate the contribution of reduced food intake versus other factors in weight loss.

Main Methods:

• Nude mice were inoculated with Chinese hamster ovary (CHO) tumor cells engineered to produce murine IFN-gamma (CHO/IFN-gamma) or control CHO cells.
• Cachexia was assessed by monitoring body weight, food intake, and interscapular fat tissue.
• Monoclonal antibodies (MAbs) against IFN-gamma were administered to evaluate their protective effect.

Main Results:

• Mice injected with CHO/IFN-gamma cells developed severe cachexia, including significant body weight loss and reduced food intake.
• Mice injected with control CHO cells did not exhibit cachexia.
• Administration of anti-IFN-gamma MAbs prevented cachexia development, confirming IFN-gamma's essential role.
• Reduced food intake partially explained weight loss; humoral factors were implicated in interscapular fat loss.

Conclusions:

• Tumor-produced Interferon-gamma (IFN-gamma) is a critical mediator in the pathogenesis of cancer-associated cachexia.
• IFN-gamma alone, in the presence of tumor cells, can induce significant weight loss and fat tissue reduction.
• These findings identify IFN-gamma as a key humoral factor driving cancer cachexia.